Total Payments
$92,802
2024 Payments
$15,971
Companies
22
Transactions
286
Medicare Patients
1,339
Medicare Billing
$176,174
Payment Breakdown by Category
Other$72,745 (78.4%)
Consulting$9,769 (10.5%)
Food & Beverage$6,037 (6.5%)
Travel$4,168 (4.5%)
Education$82.02 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56,408 | 36 | 60.8% |
| Honoraria | $16,338 | 22 | 17.6% |
| Consulting Fee | $9,769 | 8 | 10.5% |
| Food and Beverage | $6,037 | 206 | 6.5% |
| Travel and Lodging | $4,168 | 11 | 4.5% |
| Education | $82.02 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $37,152 | 44 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $26,137 | 83 | $0 (2024) |
| kaleo, Inc. | $7,401 | 23 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $6,782 | 7 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $5,990 | 16 | $0 (2024) |
| GENZYME CORPORATION | $2,669 | 42 | $0 (2024) |
| ALK-Abello, Inc | $2,335 | 5 | $0 (2022) |
| Amgen Inc. | $2,100 | 11 | $0 (2024) |
| ABBVIE INC. | $827.32 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $315.64 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,971 | 45 | kaleo, Inc. ($7,115) |
| 2023 | $16,916 | 57 | AstraZeneca Pharmaceuticals LP ($11,879) |
| 2022 | $18,616 | 87 | Aimmune Therapeutics, Inc. ($9,824) |
| 2021 | $26,711 | 60 | AIMMUNE THERAPEUTICS, INC. ($13,551) |
| 2020 | $13,671 | 10 | AIMMUNE THERAPEUTICS, INC. ($13,545) |
| 2019 | $573.06 | 16 | AstraZeneca Pharmaceuticals LP ($195.18) |
| 2018 | $299.77 | 9 | AstraZeneca Pharmaceuticals LP ($134.11) |
| 2017 | $44.00 | 2 | Teva Pharmaceuticals USA, Inc. ($26.04) |
All Payment Transactions
286 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA | Education | In-kind items and services | $22.52 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.75 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.28 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $161.00 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $116.43 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Allergy | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Respiratory | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Respiratory | ||||||
| 07/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Respiratory | ||||||
| 07/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $125.00 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | kaleo, Inc. | AUVI-Q (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,540.00 | General |
| Category: Allergy | ||||||
| 06/20/2024 | kaleo, Inc. | AUVI-Q (Drug) | Travel and Lodging | Cash or cash equivalent | $1,452.69 | General |
| Category: Allergy | ||||||
| 06/20/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Allergy | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Respiratory | ||||||
| 05/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 334 | 3,577 | $122,884 | $44,137 |
| 2022 | 7 | 308 | 2,654 | $90,281 | $40,838 |
| 2021 | 9 | 364 | 4,037 | $110,810 | $51,855 |
| 2020 | 8 | 333 | 3,174 | $90,256 | $39,343 |
Total Patients
1,339
Total Services
13,442
Medicare Billing
$176,174
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 59 | 1,315 | $39,585 | $17,432 | 44.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 59 | 931 | $36,032 | $9,424 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 50 | $11,568 | $5,353 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $9,200 | $3,622 | 39.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 14 | 798 | $12,654 | $3,060 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 31 | $4,911 | $2,431 | 49.5% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 13 | 279 | $5,185 | $2,150 | 41.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 14 | 15 | $1,372 | $351.40 | 25.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 77 | 129 | $2,378 | $314.76 | 13.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 59 | 1,365 | $36,855 | $20,074 | 54.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 60 | 1,062 | $33,984 | $10,915 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 58 | $7,656 | $4,289 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 35 | $6,650 | $3,619 | 54.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,190 | $1,285 | 40.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 15 | 17 | $1,071 | $393.24 | 36.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 76 | 106 | $874.50 | $261.96 | 30.0% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 64 | 1,395 | $35,405 | $20,924 | 59.1% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 63 | 987 | $31,584 | $10,106 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 61 | $7,992 | $4,919 | 61.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $9,570 | $4,673 | 48.8% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 19 | 1,118 | $14,534 | $4,605 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 29 | $5,510 | $3,306 | 60.0% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 15 | 299 | $4,336 | $2,573 | 59.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 15 | 17 | $1,071 | $487.52 | 45.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 76 | 98 | $808.50 | $263.15 | 32.5% |
About Dr. Ananth Thyagarajan, M.D
Dr. Ananth Thyagarajan, M.D is a Allergy & Immunology healthcare provider based in Burke, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1356516546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ananth Thyagarajan, M.D has received a total of $92,802 in payments from pharmaceutical and medical device companies, with $15,971 received in 2024. These payments were reported across 286 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($56,408).
As a Medicare-enrolled provider, Thyagarajan has provided services to 1,339 Medicare beneficiaries, totaling 13,442 services with total Medicare billing of $176,174. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Burke, VA
- Active Since 04/28/2008
- Last Updated 12/04/2024
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1356516546
Products in Payments
- PALFORZIA (Biological) $34,302
- TEZSPIRE (Biological) $17,374
- AUVI-Q (Drug) $7,333
- FASENRA (Biological) $7,114
- AirDuo RespiClick (Drug) $5,040
- DUPIXENT (Biological) $2,804
- ArmonAir Digihaler (Drug) $1,680
- RINVOQ (Biological) $827.32
- NUCALA (Biological) $315.64
- Xhance (Drug) $235.50
- DUPIXENT (Drug) $138.50
- FASENRA (Drug) $126.87
- OPZELURA (Drug) $94.69
- Xolair (Biological) $82.63
- Prolastin-C Liquid (Biological) $81.21
- AIRSUPRA (Drug) $74.30
- XOLAIR (Drug) $71.26
- Orladeyo (Drug) $70.20
- ILARIS (Biological) $68.45
- Auvi-Q (Drug) $67.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.